ArticleGene therapy2007

AAV-mediated delivery of a mutated myostatin propeptide ameliorates calpain 3 but not alpha-sarcoglycan deficiency.

M Bartoli et al.PubMed ↗Publisher ↗

No numbers read from the abstract.